US equities |
SPCX $167.07 ▲+5.10% NVDA $237.09 ▲+1.34% MU $1,063.51 ▼-1.06% TSLA $378.11 ▲+2.03% MSFT $527.20 ▲+1.87% SNDK $1,713.69 ▼-0.37% INTC $116.58 ▼-2.30% META $746.52 ▲+2.53%
FinancialContent

Articles published by ADC Therapeutics

News headline image
ADC Therapeutics to Participate in Morgan Stanley’s 20th Annual Global Healthcare Conference
From ADC Therapeutics
Via Business Wire
Tickers ADCT
News headline image
ADC Therapeutics Announces Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma
From ADC Therapeutics
Via Business Wire
Tickers ADCT
News headline image
ADC Therapeutics to Host Webcast Highlighting its ADC Platform and Solid Tumor Pipeline on February 8, 2022
From ADC Therapeutics
Via Business Wire
Tickers ADCT
News headline image
ADC Therapeutics to Participate in the Jefferies London Healthcare Conference
From ADC Therapeutics
Via Business Wire
Tickers ADCT
News headline image
Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA® in Pivotal Phase 2 Clinical Trial for Diffuse Large B-cell Lymphoma
From ADC Therapeutics
Via Business Wire
Tickers ADCT